Literature DB >> 15896865

Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model.

Soon-Tae Lee1, Kon Chu, Jung-Eun Park, Kyungmi Lee, Lami Kang, Seung U Kim, Manho Kim.   

Abstract

An animal model induced by striatal quinolinic acid (QA) injection shows ongoing striatal degeneration mimicking Huntington's disease. To study the migratory ability and the neuroprotective effect of human neural stem cells (NSCs) in this model, we transplanted NSCs (5 x 10(6)) or saline intravenously at 7 days after unilateral QA injection. NSCs-group exhibited the reduced apomorphine-induced rotation and the reduced striatal atrophy compared to the control. PCR analysis for the human-specific ERV-3 gene supported an evidence of the engraftment of human NSCs in the rat brain. X-gal+ cells were found in and around the damaged striatum and migrated NSCs differentiated into neurons and glias. This result indicates that intravenously injected human NSCs can migrate into the striatal lesion, decrease the following striatal atrophy, and induce long-term functional improvement in a glutamate toxicity-induced striatal degeneration model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896865     DOI: 10.1016/j.neures.2005.03.016

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  41 in total

1.  System approaches reveal the molecular networks involved in neural stem cell differentiation.

Authors:  Kai Wang; Haifeng Wang; Jiao Wang; Yuqiong Xie; Jun Chen; Huang Yan; Zengrong Liu; Tieqiao Wen
Journal:  Protein Cell       Date:  2012-04-10       Impact factor: 14.870

2.  Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease.

Authors:  Kyle D Fink; Andrew T Crane; Xavier Lévêque; Dylan J Dues; Lucas D Huffman; Allison C Moore; Darren T Story; Rachel E Dejonge; Aaron Antcliff; Phillip A Starski; Ming Lu; Laurent Lescaudron; Julien Rossignol; Gary L Dunbar
Journal:  Stem Cells Transl Med       Date:  2014-03-21       Impact factor: 6.940

Review 3.  Stem Cells Transplantation and Huntington's Disease.

Authors:  Wooseok Im; Soon-Tae Lee; Kon Chu; Manho Kim; Jae-Kyu Roh
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

Review 4.  Human nerual stem cells for brain repair.

Authors:  Seung U Kim; Hong J Lee; In H Park; Kon Chu; Soon T Lee; Manho Kim; Jae K Roh; Seung K Kim; Kyu C Wang
Journal:  Int J Stem Cells       Date:  2008-11       Impact factor: 2.500

Review 5.  Immune influence on adult neural stem cell regulation and function.

Authors:  Pamela A Carpentier; Theo D Palmer
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

Review 6.  PET molecular imaging in stem cell therapy for neurological diseases.

Authors:  Jiachuan Wang; Mei Tian; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-23       Impact factor: 9.236

7.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

8.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

9.  Therapeutic Strategies in Huntington's Disease.

Authors:  Ichiro Kanazawa
Journal:  J Clin Neurol       Date:  2006-12-20       Impact factor: 3.077

10.  Biological studies on alcohol-induced neuronal damage.

Authors:  Masaru Tateno; Toshikazu Saito
Journal:  Psychiatry Investig       Date:  2008-03-31       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.